Skip to main content

Articles

Page 38 of 70

  1. To compare the prognostic value of different anatomical and functional metabolic parameters determined using [18F]FDG-PET/CT with other clinical and pathological prognostic parameters in cervical cancer (CC).

    Authors: Fernanda G. Herrera, Thomas Breuneval, John O. Prior, Jean Bourhis and Mahmut Ozsahin
    Citation: Radiation Oncology 2016 11:43
  2. Intraoperative electron radiotherapy (IOERT) is a highly selective radiotherapy technique which aims to treat restricted anatomic volumes during oncological surgery and is now the subject of intense re-evaluat...

    Authors: Juan López-Tarjuelo, Virginia Morillo-Macías, Ana Bouché-Babiloni, Enrique Boldó-Roda, Rafael Lozoya-Albacar and Carlos Ferrer-Albiach
    Citation: Radiation Oncology 2016 11:41
  3. Stereotactic ablative volume reduction (SAVR) is a potential alternative to lung-volume reduction surgery in patients with severe emphysema and excessive surgical risk. Having previously observed a dose-volume...

    Authors: Michael S. Binkley, Joseph B. Shrager, Aadel Chaudhuri, Rita Popat, Peter G. Maxim, David Benjamin Shultz, Maximilian Diehn and Billy W. Loo Jr
    Citation: Radiation Oncology 2016 11:40
  4. Patients with large, locally advanced cervical cancers (LACC) are challenging to treat. The purpose of this work is to use 18F-FDG PET as planning basis for a short-course simultaneous integrated boost (SIB) i...

    Authors: Marius Røthe Arnesen, Bernt Louni Rekstad, Caroline Stokke, Kjersti Bruheim, Ayca Muftuler Løndalen, Taran Paulsen Hellebust and Eirik Malinen
    Citation: Radiation Oncology 2016 11:39
  5. To build a new treatment planning approach that extends beyond radiation transport and IMRT optimization by modeling the radiation therapy process and prognostic indicators for more outcome-focused decision ma...

    Authors: Wade P. Smith, Minsun Kim, Clay Holdsworth, Jay Liao and Mark H. Phillips
    Citation: Radiation Oncology 2016 11:38
  6. In order to define adequate radiation portals in nodal positive prostate cancer a detailed knowledge of the anatomic lymph-node distribution is mandatory. We therefore systematically analyzed the localization ...

    Authors: Nina-Sophie Hegemann, Vera Wenter, Sonja Spath, Nadia Kusumo, Minglun Li, Peter Bartenstein, Wolfgang P. Fendler, Christian Stief, Claus Belka and Ute Ganswindt
    Citation: Radiation Oncology 2016 11:37
  7. Unscheduled accelerator downtime can negatively impact the quality of life of patients during their struggle against cancer. Currently digital data accumulated in the accelerator system is not being exploited ...

    Authors: Charles M. Able, Alan H. Baydush, Callistus Nguyen, Jacob Gersh, Alois Ndlovu, Igor Rebo, Jeremy Booth, Mario Perez, Benjamin Sintay and Michael T. Munley
    Citation: Radiation Oncology 2016 11:36
  8. It is unknown if survival prediction tools (SPTs) sufficiently predict survival in patients who undergo palliative reirradiation of spinal metastases. We therefore set out to clarify if SPTs can predict surviv...

    Authors: Daniel Buergy, Lena Siedlitzki, Judit Boda-Heggemann, Frederik Wenz and Frank Lohr
    Citation: Radiation Oncology 2016 11:35
  9. Definitive radiotherapy is often used for chest wall desmoid tumours due to size or anatomical location. The delivery of radiotherapy is challenging due to the large size and constraints of normal surrounding ...

    Authors: Jia Liu, Diana Ng, James Lee, Paul Stalley and Angela Hong
    Citation: Radiation Oncology 2016 11:34
  10. The aim of this study was to investigate the potential of the flattening filter free (FFF) mode of a linear accelerator for intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VM...

    Authors: Barbara Dobler, Amine Khemissi, Tina Obermeier, Matthias G. Hautmann, Zaira Katsilieri and Oliver Kölbl
    Citation: Radiation Oncology 2016 11:33
  11. To evaluate acute toxicity endpoints in a cohort of patients receiving head and neck radiation with proton therapy or intensity modulated radiation therapy (IMRT).

    Authors: Mark W. McDonald, Yuan Liu, Michael G. Moore and Peter A. S. Johnstone
    Citation: Radiation Oncology 2016 11:32
  12. Salvage endoscopic therapy (SET), such as endoscopic mucosal resection (EMR) and photodynamic therapy (PDT), is a less-invasive treatment for local failure at the primary site after chemoradiotherapy (CRT) for...

    Authors: Ken Hatogai, Tomonori Yano, Takashi Kojima, Masakatsu Onozawa, Satoshi Fujii, Hiroyuki Daiko, Yusuke Yoda, Takuya Hombu, Toshihiko Doi, Kazuhiro Kaneko and Atsushi Ohtsu
    Citation: Radiation Oncology 2016 11:31
  13. Through the Monte Carlo (MC) simulation of 6 and 10 MV flattening-filter-free (FFF) beams from Varian TrueBeam accelerator, this study aims to find the best incident electron distribution for further studying ...

    Authors: Zhongsu Feng, Haizhen Yue, Yibao Zhang, Hao Wu, Jinsheng Cheng and Xu Su
    Citation: Radiation Oncology 2016 11:30
  14. Accelerated partial breast irradiation (APBI) is a new breast treatment modality aiming to reduce treatment time using hypo fractionation. Compared to conventional whole breast irradiation that takes 5 to 6 we...

    Authors: Erwann Rault, Thomas Lacornerie, Hong-Phuong Dang, Frederik Crop, Eric Lartigau, Nick Reynaert and David Pasquier
    Citation: Radiation Oncology 2016 11:29
  15. Radiotherapy of central lung tumors carries a higher risk of treatment-related toxicity and local failure. In the era of aggressive oligometastic management the exploration of the proper dose-fractionation for...

    Authors: Jonathan W. Lischalk, Ryan M. Malik, Sean P. Collins, Brian T. Collins, Ismael A. Matus and Eric D. Anderson
    Citation: Radiation Oncology 2016 11:28
  16. To analyse and compare the costs of hepatic tumor ablation with computed tomography (CT)-guided high-dose rate brachytherapy (CT-HDRBT) and CT-guided radiofrequency ablation (CT-RFA) as two alternative minimal...

    Authors: D. Schnapauff, F. Collettini, I. Steffen, G. Wieners, B. Hamm, B. Gebauer and M. H. Maurer
    Citation: Radiation Oncology 2016 11:26
  17. To evaluate the efficacy of postoperative radiotherapy (RT) on local failure-free survival (LFFS), distant metastasis-free survival (DMFS) and overall survival (OS) in patients with localized primary soft tiss...

    Authors: Ru-Ping Zhao, Xiao-Li Yu, Zhen Zhang, Li-Juan Jia, Yan Feng, Zhao-Zhi Yang, Xing-Xing Chen, Jian Wang, Sheng-Lin Ma and Xiao-Mao Guo
    Citation: Radiation Oncology 2016 11:25
  18. Neoadjuvant CRT may lead to significant tumor regression in patients with rectal cancer. Different CRT regimens with consolidation chemotherapy may lead to increased rates of complete tumor regression. The pur...

    Authors: Angelita Habr-Gama, Rodrigo O. Perez, Guilherme P. São Julião, Igor Proscurshim, Laura M. Fernandez, Marleny N. Figueiredo, Joaquim Gama-Rodrigues and Carlos A. Buchpiguel
    Citation: Radiation Oncology 2016 11:24
  19. The aim of this work is to develop an algorithm to predict recurrence in prostate cancer patients treated with radical radiotherapy, getting up to a prognostic power higher than traditional D’Amico risk classi...

    Authors: Domenico Gabriele, Barbara A Jereczek-Fossa, Marco Krengli, Elisabetta Garibaldi, Maria Tessa, Gregorio Moro, Giuseppe Girelli and Pietro Gabriele
    Citation: Radiation Oncology 2016 11:23
  20. This study aimed to evaluate the effect of stereotactic ablative radiotherapy (SABR) after incomplete transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC) patients.

    Authors: Eun Kyung Paik, Mi-Sook Kim, Won Il Jang, Young Seok Seo, Chul-Koo Cho, Hyung Jun Yoo, Chul Ju Han, Su Cheol Park, Sang Bum Kim and Young Han Kim
    Citation: Radiation Oncology 2016 11:22
  21. The benefit of hyperthermia as a potent modifier of radiotherapy has been well established and more recently also the combination with chemotherapy was shown beneficial. Also for head and neck cancer, the impa...

    Authors: Margarethus M. Paulides, Gerda M. Verduijn and Netteke Van Holthe
    Citation: Radiation Oncology 2016 11:21
  22. The relationship between oesophageal radiation dose volume metrics and dysphagia in patients having chemoradiation (CRT) for non-small cell lung cancer (NSCLC) is well established. There is also some evidence ...

    Authors: Sarah Everitt, Mary Duffy, Mathias Bressel, Belinda McInnes, Christine Russell, Tim Sevitt and David Ball
    Citation: Radiation Oncology 2016 11:20
  23. The first aim of this study was to assess plan quality using a conformity index (CI) and analyse its influence on patient outcome. The second aim was to identify whether clinical and technological factors incl...

    Authors: Rhys Carrington, Emiliano Spezi, Sarah Gwynne, Peter Dutton, Chris Hurt, John Staffurth and Thomas Crosby
    Citation: Radiation Oncology 2016 11:19
  24. Radiotherapy has a central role in the treatment of sinonasal malignancies, either as postoperative or as primary therapy. To study the efficacy and safety of intensity modulated radiotherapy (IMRT) for sinona...

    Authors: Vasileios Askoxylakis, Pia Hegenbarth, Carmen Timke, Ladan Saleh-Ebrahimi, Juergen Debus, Falk Röder and Peter E. Huber
    Citation: Radiation Oncology 2016 11:17
  25. Locoregional hyperthermia combined with radiotherapy significantly improves locoregional control and overall survival for cervical tumors compared to radiotherapy alone. In this study biological modelling is a...

    Authors: J. Crezee, C. M. van Leeuwen, A. L. Oei, L. E. van Heerden, A. Bel, L. J. A. Stalpers, P. Ghadjar, N. A. P. Franken and H. P. Kok
    Citation: Radiation Oncology 2016 11:14
  26. To investigate the feasibility of a novel dedicated treatment planning solution, to automatically target multiple brain metastases with a single isocenter and multiple inversely-optimized dynamic conformal arc...

    Authors: Thierry Gevaert, Femke Steenbeke, Luca Pellegri, Benedikt Engels, Nicolas Christian, Marie-Thérèse Hoornaert, Dirk Verellen, Carine Mitine and Mark De Ridder
    Citation: Radiation Oncology 2016 11:13
  27. To assess efficacy of our single-centre experience with inhalative steroids (IS) in lung cancer patients with symptomatic radiation pneumonitis (RP) grade II.

    Authors: C. Henkenberens, S. Janssen, M. Lavae-Mokhtari, K. Leni, A. Meyer, H. Christiansen, M. Bremer and N. Dickgreber
    Citation: Radiation Oncology 2016 11:12
  28. The aim of this study is to evaluate the radiobiological impact of Acuros XB (AXB) vs. Anisotropic Analytic Algorithm (AAA) dose calculation algorithms in combined dose-volume and biological optimized IMRT pla...

    Authors: X. Liang, J. Penagaricano, D. Zheng, S. Morrill, X. Zhang, P. Corry, R. J. Griffin, E. Y. Han, M. Hardee and V. Ratanatharathom
    Citation: Radiation Oncology 2016 11:10
  29. A new entity of patients with recurrent prostate cancer limited to a small number of active metastatic lesions is having growing interest: the oligometastatic patients. Patients with oligometastatic disease co...

    Authors: Francesco Pasqualetti, Marco Panichi, Aldo Sainato, Fabrizio Matteucci, Luca Galli, Paola Cocuzza, Patrizia Ferrazza, Gabriele Coraggio, Giuseppe Pasqualetti, Lisa Derosa, Martina Sollini, Lorenzo Mannelli, Simona Ortori, Fabio Monzani, Sergio Ricci, Carlo Greco…
    Citation: Radiation Oncology 2016 11:9
  30. Treatment of intermediate and high-risk prostate cancer with a high BED has been shown to increase recurrence free survival (RFS). While high dose rate (HDR) brachytherapy, given as a boost is effective in del...

    Authors: Mekhail Anwar, Vivian Weinberg, Zachary Seymour, I. Joe Hsu, Mack Roach III and Alex R. Gottschalk
    Citation: Radiation Oncology 2016 11:8
  31. The EORTC has launched a phase II trial to assess safety and efficacy of SBRT for centrally located NSCLC: The EORTC 22113-08113—Lungtech trial. Due to neighbouring critical structures, these tumours remain ch...

    Authors: Marie Lambrecht, Christos Melidis, Jan-Jakob Sonke, Sonja Adebahr, Ronald Boellaard, Marcel Verheij, Matthias Guckenberger, Ursula Nestle and Coen Hurkmans
    Citation: Radiation Oncology 2016 11:7
  32. After the failure of first-line treatment, the clinical prognosis in head and neck cancer (HNSCC) deteriorates. Effective therapeutic strategies are limited due to the toxicity of previous treatments and the d...

    Authors: M. Ritter, I. U. Teudt, J. E. Meyer, U. Schröder, G. Kovács and B. Wollenberg
    Citation: Radiation Oncology 2016 11:6
  33. To evaluate clinical outcomes of stereotactic body radiotherapy (SBRT) for localized primary and oligometastatic lung tumors by assessing efficacy and safety of 5 regimens of varying fraction size and number.

    Authors: Masahiko Aoki, Yoshiomi Hatayama, Hideo Kawaguchi, Katsumi Hirose, Mariko Sato, Hiroyoshi Akimoto, Ichitaro Fujioka, Shuichi Ono, Eiki Tsushima and Yoshihiro Takai
    Citation: Radiation Oncology 2016 11:5
  34. Standard chemoradiotherapy (CRT) using cisplatin (CDDP) and 5-fluorouracil (5-FU) is an optional treatment for patients with stage II-III esophageal cancer. However, there are some demerits in this regimen bec...

    Authors: Hideomi Yamashita, Akihiro Haga, Ryousuke Takenaka, Tomoki Kiritoshi, Kae Okuma, Kuni Ohtomo and Keiichi Nakagawa
    Citation: Radiation Oncology 2016 11:4
  35. Hypofractionated three-dimensional conformal radiation therapy (3D-CRT) is a treatment option for patients with early-stage non-small cell lung cancer (NSCLC) who are medically unable to tolerate surgery and w...

    Authors: Masakuni Sakaguchi, Toshiya Maebayashi, Takuya Aizawa, Naoya Ishibashi, Shoko Fukushima, Osamu Abe and Tsutomu Saito
    Citation: Radiation Oncology 2016 11:3
  36. To verify the accuracy of volumetric arc therapy (VMAT) using the RapidArcâ„¢ device when switching patients from one single linear accelerator (linac) to a paired energy and mechanics "twin" linac without reopt...

    Authors: P. Fenoglietto, M. Khodri, D. Nguyen, F. Josserand-Pietri and N. Aillères
    Citation: Radiation Oncology 2016 11:2
  37. The present study aimed to define the optimal number of atlases for automatic multi-atlas-based brachial plexus (BP) segmentation and to compare Simultaneous Truth and Performance Level Estimation (STAPLE) lab...

    Authors: Joris Van de Velde, Johan Wouters, Tom Vercauteren, Werner De Gersem, Eric Achten, Wilfried De Neve and Tom Van Hoof
    Citation: Radiation Oncology 2016 11:1
  38. We investigated the clinical outcome and the toxicity of trimodal therapy of malignant pleural mesothelioma (MPM) treated with neoadjuvant chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant intensity-...

    Authors: Christian Thieke, Nils H. Nicolay, Florian Sterzing, Hans Hoffmann, Falk Roeder, Seyer Safi, Juergen Debus and Peter E. Huber
    Citation: Radiation Oncology 2015 10:267
  39. Total body irradiation (TBI) has been part of standard conditioning regimens before allogeneic stem cell transplantation for many years. Its effect on normal tissue in these patients has not been studied exten...

    Authors: G. Massenkeil, P. Zschieschang, G. Thiel, P. G. Hemmati, V. Budach, B. Dörken, J. Pross and R. Arnold
    Citation: Radiation Oncology 2015 10:266
  40. Around 27,000 new cases of prostate cancer are diagnosed every year in Spain and 5400 die from this disease. Radiotherapy (RT), alone or combined, has proven to be effective as initial treatment in patients wi...

    Authors: José Expósito, Isabel Linares, Isabel Castillo, Miguel Martínez, Pilar Vargas, Ismael Herruzo, José Antonio Medina, Amalia Palacios, Eloísa Bayo, Francisco Peracaula, Javier Jaén, José Antonio Sánchez and María José Ortiz
    Citation: Radiation Oncology 2015 10:265
  41. Radiation therapy (RT) for a left-sided breast cancer often involves some incidental exposure of the heart and increase in the rate of major coronary events. One method to reduce the dose to the heart during a...

    Authors: Ji Hyeon Joo, Su Ssan Kim, Seung Do Ahn, Jungwon Kwak, Chiyoung Jeong, Sei-Hyun Ahn, Byung-Ho Son and Jong Won Lee
    Citation: Radiation Oncology 2015 10:264
  42. The choice of any radiotherapy treatment plan is usually made after the evaluation of a few preliminary isodose distributions obtained from different beam configurations. Despite considerable advances in plann...

    Authors: J. C. L. Alfonso, M. A. Herrero and L. Núñez
    Citation: Radiation Oncology 2015 10:263
  43. Little is known about the clinical impact of using multiparametric MRI to plan early salvage radiotherapy after radical prostatectomy. We aimed to evaluate the incidence and location of recurrence based on pel...

    Authors: D. Hernandez, D. Salas, D. Giménez, P. Buitrago, S. Esquena, J. Palou, P. de la Torre, J. Pernas, I. Gich, G. Gómez de Segura, J. Craven-Bartle and G. Sancho
    Citation: Radiation Oncology 2015 10:262
  44. The last few years, in radiotherapy there has been a growing focus on speed of treatment delivery (largely driven by economical and commercial interests). This study investigates the influence of treatment tim...

    Authors: Dirk Van Gestel, Geert De Kerf, Kristien Wouters, Wouter Crijns, Jan B. Vermorken, Vincent Gregoire and Dirk Verellen
    Citation: Radiation Oncology 2015 10:261
  45. The present study aimed to measure the effect of a morphometric atlas selection strategy on the accuracy of multi-atlas-based BP autosegmentation using the commercially available software package ADMIRE® and t...

    Authors: Joris Van de Velde, Johan Wouters, Tom Vercauteren, Werner De Gersem, Eric Achten, Wilfried De Neve and Tom Van Hoof
    Citation: Radiation Oncology 2015 10:260

Annual Journal Metrics

  • 2022 Citation Impact
    3.6 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.370 - SNIP (Source Normalized Impact per Paper)
    1.037 - SJR (SCImago Journal Rank)

    2023 Speed
    16 days submission to first editorial decision for all manuscripts (Median)
    132 days submission to accept (Median)

    2023 Usage 
    1,958,690 downloads
    605 Altmetric mentions